These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12722692)

  • 1. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and problems in development of molecular target agents for gastrointestinal malignancy in Japan.
    Boku N
    Jpn J Clin Oncol; 2010 Mar; 40(3):183-7. PubMed ID: 20047861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Participation in the global study. Activities and issues from the bedside].
    Yamamoto N
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):316-9. PubMed ID: 17301553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress of clinical trials in urologic oncology].
    Hinotsu S
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):188-92. PubMed ID: 16484854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Participation to international registration trials--from the investigator's standpoint].
    Ohtsu A
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):297-300. PubMed ID: 17301548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
    Ekimoto H
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infrastructure of cancer clinical trial cooperative groups in western countries].
    Fukuda H
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of an anticancer drug in Japan based on a new clinical trial system].
    Nakashima H; Nakano S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):287-94. PubMed ID: 9492818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Need to establish academic research organization for cancer clinical trial and clinical research system having clinical investigators and study coordinators, with special reference to promotion of medical and life science research policy].
    Shimoyama M
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):235-46. PubMed ID: 9987525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer prevention].
    Akaza H; Tsuruo T; Saijo N; Sone S; Isonishi S; Ohashi Y; Noguchi S; Kurebayashi J; Kakehi Y; Ishikawa H; Blackledge G
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1499-506. PubMed ID: 16227757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trials for gynecological cancers (especially ovarian cancers) in Japan, current situation and problems--focusing on differences in the system of study used by Japanese Study Group and the Gynecologic Oncology Group in the United States].
    Fujiwara K; Kohno I
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():395-401. PubMed ID: 7986120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group.
    Nabholtz JM; Lindsay MA; Hugh J; Mackey J; Smylie M; Au HJ; Tonkin K; Allen M
    Semin Oncol; 1999 Jun; 26(3 Suppl 8):4-8. PubMed ID: 10403467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.
    Sakamoto J; Morita S; Kodera Y; Rahman M; Nakao A
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the Japan Clinical Oncology Group].
    Ohe Y; Saijo N
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1127-32. PubMed ID: 10945006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.